Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer||
||Other / NIH||
||35||Female||18 Years and older (Adult, Older Adult)||NCT01210222||GOG-0229L
|June 6, 2011||July 16, 2016||July 16, 2016||September 28, 2010||February 23, 2018||November 29, 2017||